The global Next-Generation Sequencing Data Analysis Market is expected to reach USD 4,556.9 million by 2030, registering a CAGR of 22.89% over the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to a significant decline in the cost of NGS installation in clinical diagnosis. Furthermore, the accessibility of genomic and proteomic data is anticipated to create significant growth opportunities. In addition, a reduction in the cost of sequencing is anticipated to boost the adoption rate of NGS, which would further drive the industry. The availability of tools, such as the Targeted Methyl-Seq platform and Agilent’s HaloPlex capture system from EpiGentek Group Inc. has aided in the DNA methylation profiles determination in individual genomes. The COVID-19 pandemic has enhanced NGS usage and has created a huge demand.
The
NGS tools can generate a significant amount of data for scientists to analyze
and study pathogenesis. Researchers from industry, academia, and government
have used data analysis technology to help in understanding the
characteristics, phylogenetics, and processes of SARS-CoV2. NGS technologies
have helped to unveil biological information that has not been studied yet
using conventional technologies. For instance, NGS has helped study genomic
patterns associated with various biological processes and epigenomics. However,
issues related to accessing storage management, and analysis of data are anticipated
to offer huge R&D prospects, thus, driving the industry growth. Researchers
that use high-throughput sequencers demand software systems, such as Laboratory
Information Management Systems (LIMS) to archive and handle sequencing
information.
Furthermore,
the introduction of workflow management system solutions, such as Galaxy and
Chipster, drives demand for technological advancements in data storage and
management. Demand for technologically advanced infrastructure to monitor the
flow of data analysis process from data generation to preliminary analysis to
higher-level analysis has increased. Moreover, NGS data analysis tools are
being constantly upgraded for obtaining effective results and higher utility.
For instance, in December 2021, Bionano Genomics launched BioDiscovery’s
NxClinical Software Version 6.1 for genome analysis. The version enables
enhanced visualization and interpretation of NGS data for cancer and genetic
disease domains. Such developments are anticipated to drive the industry over
the forecast period.
List of Key Players in Next-generation Sequencing Data
Analysis Market
- Golden
Helix, Inc.
- Bio-Rad
Laboratories, Inc.
- SciGenom
Labs Pvt. Ltd.
- DNAnexus
Inc.
- Genuity
Science
- Fabric
Genomics, Inc.
- Congenica
Ltd.
- QIAGEN
- DNASTAR,
Inc.
- Pacific
Biosciences of California, Inc.
- Eurofins
Scientific
- Partek
Incorporated
- Precigen
Bioinformatics Germany GmbH
- PierianDx
- Agilent
Technologies, Inc.
- F.
Hoffmann-La Roche Ltd.
- Illumina,
Inc.
- Verily Life
Science
- Thermo
Fisher Scientific, Inc.
Related Press
Release@ Next-generation Sequencing Data Analysis Market Report
Next-generation Sequencing Data Analysis Market Report
Highlights
- The services
product segment dominated the industry in 2022. NGS has several
advantages, in terms of speed and affordability, and many research
institutes are unable to adopt it due to a lack of skilled professionals
and sufficient computational infrastructure
- The tertiary
analysis workflow segment captured the major revenue share in 2022 as it
accounts for the complex and important step of NGS, which is linked with
the interpretation of the results
- The in-house
mode segment dominated the market in 2022 and is anticipated to remain
dominant in the coming years. However, the outsourced mode segment is
anticipated to witness the fastest growth rate from 2023 to 2030 owing to
time and cost advantages
- The
short-read sequencing segment held the maximum share in 2022 due to the
high adoption of short-read sequencing techniques and their cost-effective
nature & ability to work with DNA fragments and the availability of
several tools & algorithms
- The academic
research end-use segment dominated the market in 2022. A reduction in the
NGS technology cost has fueled the NGS software platforms usage by several
research centers & academic institutions for their research that
require data interpretation
- North America
captured the highest revenue share in 2022 owing to the presence of
well-developed information technology companies, favorable reimbursement
network, and high government funding and high public & private
expenditures in the biotechnology sector
Next-generation Sequencing Data
Analysis Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2023 |
USD 1,076.8 million |
|
Revenue forecast in 2030 |
USD 4,556.9 million |
|
Growth rate |
CAGR of 22.89% from 2023 to 2030 |
|
Base year for estimation |
2022 |
|
Historical data |
2018 - 2021 |
|
Forecast period |
2023 - 2030 |
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/3100/rfc
Next-generation Sequencing Data Analysis Market
Segmentation
Grand
View Research has segmented the global next-generation sequencing data analysis
market based on product, workflow, mode, end-use, read length, and region:
Next-generation Sequencing Data Analysis Product Outlook
(Revenue, USD Million, 2018 - 2030)
- Services
- NGS
Commercial Software
- Platform
OS/UI
- Analytical
Software
- QC/Pre-processing
Tools
- Alignment
Tools & Software
- DNA
Sequencing Alignment
- RNA
Sequencing Alignment
- Protein
Sequencing Alignment
- Others
Next-generation Sequencing Data Analysis Workflow Outlook
(Revenue, USD Million, 2018 - 2030)
- Primary
- Secondary
- Read
Mapping
- Variant
Alignment & Variant Calling
- Tertiary
- Variant
Annotation
- Application
Specific
- Targeted
Sequencing/Gene Panel
- Exome
- RNA
Sequencing
- Whole
Genome
- Chip
Sequencing
- Others
Next-generation Sequencing Data Analysis Mode Outlook
(Revenue, USD Million, 2018 - 2030)
- In-house
- Outsourced
Next-generation Sequencing Data Analysis Read Length
Outlook (Revenue, USD Million, 2018 - 2030)
- Short Read
Sequencing
- Long Read
Sequencing
- Very Long
Read Sequencing
Next-generation Sequencing Data Analysis End-use Outlook
(Revenue, USD Million, 2018 - 2030)
- Academic
Research
- Clinical
Research
- Hospitals
& Clinics
- Pharma &
Biotech Entities
- Other Users
Next-generation Sequencing Data Analysis Regional Outlook
(Revenue, USD Million, 2018 - 2030)
- North
America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin
America
- Brazil
- Mexico
- Argentina
- Middle East
Africa (MEA)
- South
Africa
- Saudi
Arabia
- UAE
- Kuwait
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment